Kristin Raudsepp, director general of Estonia’s drug regulator – the State Agency of Medicines – discusses her organization’s mandate, current priorities, and reactiveness to the pervading trends in international regulation.
Can you introduce the State Agency of Medicines of Estonia and its mandate to our international readers?
"Despite of the Agency’s smallness we have earned the recognition in the comparative measurements of European agencies of medicines, and the professionalism of our employees and experts is valued in the European Medicines Agency (EMA) and other International organisations, e.g. World Health Organisation (WHO)."
